Allergan board member buys $1.9 million in shares
Christopher J Coughlin, a member of the board of directors at Allergan (AGN), bought 10,000 shares of the company’s common stock on Sept 6. At $190.64 per share, Coughlin paid a total of $1,906,394 for the new shares.
Already a member?
Login to see your Insider Activity Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About Allergan plc
Allergan is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. In 2016, Allergan sold its generics and distribution segments to Teva.